Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine plus adductor canal block for analgesia after knee surgery
PACTR202304775359949Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Kafr Elsheikh University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine, sponsored by Faculty of Medicine, Kafr Elsheikh University. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on PACTR202304775359949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202304775359949.